{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:49:15Z","timestamp":1791856155830,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.contraception.2012.09.003","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T19:46:38Z","timestamp":1371152798000},"page":"364-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effect of a new oral contraceptive with estradiol valerate\/dienogest on carbohydrate metabolism"],"prefix":"10.1016","volume":"88","author":[{"given":"Vincenzo","family":"De Leo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Fruzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Musacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Scolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.09.003_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2012.09.003_bb0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humupd\/5.6.721","article-title":"Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks","volume":"5","author":"Farley","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.09.003_bb0015","first-page":"1","article-title":"The influence of female sex steroids on glucose metabolism and insulin action","volume":"738","author":"Godsland","year":"1996","journal-title":"J Intern Med Suppl"},{"key":"10.1016\/j.contraception.2012.09.003_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","article-title":"Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism","volume":"57","author":"Crook","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.003_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2008.09.002","article-title":"Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial","volume":"79","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.003_bb0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.contraception.2007.05.080","article-title":"Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention","volume":"76","author":"Fruzzetti","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.003_bb0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2005.09.014","article-title":"Effects of two different oral contraceptives on total body water: a randomized study","volume":"73","author":"Machado","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.003_bb0040","first-page":"CD006133","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","volume":"4","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.09.003_bb0045","doi-asserted-by":"crossref","unstructured":"Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord; Published, online 03\u201305\u20132011.","DOI":"10.1007\/s11154-011-9182-4"},{"key":"10.1016\/j.contraception.2012.09.003_bb0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1358\/dot.2008.44.12.1299292","article-title":"Hormonal contraception: present and future","volume":"44","author":"Benagiano","year":"2008","journal-title":"Drugs Today"},{"key":"10.1016\/j.contraception.2012.09.003_bb0055","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14656561003724713","article-title":"Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest","volume":"11","author":"Jensen","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.contraception.2012.09.003_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.maturitas.2005.01.004","article-title":"The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis","volume":"52","author":"Eilertsen","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.09.003_bb0065","doi-asserted-by":"crossref","unstructured":"Hoy SM, Scott LJ, Estradiol valerate\/dienogest in oral contraception. Drugs 2009; 20;69:1635\u201346. Review.","DOI":"10.2165\/11202820-000000000-00000"},{"key":"10.1016\/j.contraception.2012.09.003_bb0070","unstructured":"Parke S, Nahum G, Mellinger U, Junge W. Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol 2008;111 (4 Suppl)12:3."},{"key":"10.1016\/j.contraception.2012.09.003_bb0075","first-page":"499","article-title":"A 19-norprogestin without a 17a-ethinyl group I: dienogest from a pharmacokinetic point of view","volume":"31","author":"Oettel","year":"1995","journal-title":"Drugs Today"},{"key":"10.1016\/j.contraception.2012.09.003_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.09.003_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"De Leo","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.09.003_bb0090","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.09.003_bb0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/humrep\/del407","article-title":"Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis","volume":"22","author":"Nader","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.09.003_bb0100","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2012.09.003_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9378(78)90480-5","article-title":"Effect of estrogen treatment for one year on carbohydrate and lipid metabolism in women with normal and abnormal glucose tolerance test results. Glucose, insulin, growth hormone, triglycerides, and Premarin","volume":"131","author":"Spellacy","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.003_bb0110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0026-0495(82)90143-3","article-title":"The effects of two years of mestranol treatment on carbohydrate metabolism","volume":"31","author":"Spellacy","year":"1982","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2012.09.003_bb0115","first-page":"64","article-title":"Insulin resistance, secretion, and metabolism in users of oral contraceptives","volume":"74","author":"Godsland","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.09.003_bb0120","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/0002-9378(93)90432-I","article-title":"Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives","volume":"169","author":"Kojima","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.09.003_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13625189909085259","article-title":"The pharmacological profile of dienogest","volume":"4","author":"Oettel","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241200813X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241200813X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:45:04Z","timestamp":1761432304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241200813X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S001078241200813X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.09.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718339743.793493459","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a new oral contraceptive with estradiol valerate\/dienogest on carbohydrate metabolism","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}